Throughout the COVID-19 pandemic, messenger RNA, or mRNA, has been in the spotlight for the critical role it's playing in the first-ever approved mRNA vaccine. But in fact, Pfizer and BioNTech had entered into a worldwide collaboration agreement in 2018 to work on an mRNA vaccine for a different virus.
